RNARevive is a science-based biotechnology company developing self-amplifying RNA (saRNA) therapeutics designed to deliver durable protein expression from a single low dose. Instead of manufacturing therapeutic proteins outside the body, we deliver a temporary RNA instruction that enables a patient’s own cells to produce the medicine for an extended period of time.
Our mission is to reduce treatment burden and expand access to next-generation biologics—starting with age-related bone loss and tissue regeneration, and expanding into other high-impact indications where durability can transform care.
